SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 3 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $364 | +5.8% | 3 | 0.0% | 0.00% | – |
Q2 2023 | $344 | -99.0% | 3 | -98.8% | 0.00% | -100.0% |
Q1 2023 | $35,147 | +7.2% | 255 | +0.8% | 0.00% | 0.0% |
Q4 2022 | $32,784 | +17.1% | 253 | +1.2% | 0.00% | 0.0% |
Q3 2022 | $28,000 | +47.4% | 250 | 0.0% | 0.00% | +50.0% |
Q2 2022 | $19,000 | -5.0% | 250 | -83.2% | 0.00% | -77.8% |
Q1 2015 | $20,000 | -9.1% | 1,490 | 0.0% | 0.01% | +200.0% |
Q4 2014 | $22,000 | -26.7% | 1,490 | +4.2% | 0.00% | -40.0% |
Q3 2014 | $30,000 | -30.2% | 1,430 | 0.0% | 0.01% | -37.5% |
Q2 2014 | $43,000 | – | 1,430 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Evolutionary Tree Capital Management, LLC | 68,937 | $5,138,000 | 3.04% |
Avoro Capital Advisors LLC | 2,150,000 | $160,240,000 | 2.77% |
Casdin Capital, LLC | 550,000 | $40,992,000 | 1.22% |
TOBAM | 371,107 | $27,659,000 | 1.18% |
Ikarian Capital, LLC | 455,900 | $33,978,000 | 1.14% |
Eventide Asset Management | 697,156 | $51,959,000 | 0.77% |
FOX RUN MANAGEMENT, L.L.C. | 4,902 | $365,000 | 0.66% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 31,500 | $2,348,000 | 0.62% |
Sivik Global Healthcare LLC | 20,000 | $1,491,000 | 0.54% |
Rock Springs Capital Management LP | 328,750 | $24,502,000 | 0.54% |